BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Girodon E, Sternberg D, Chazouillères O, Cazeneuve C, Huot D, Calmus Y, Poupon R, Goossens M, Housset C. Cystic fibrosis transmembrane conductance regulator (CFTR) gene defects in patients with primary sclerosing cholangitis. J Hepatol 2002;37:192-7. [PMID: 12127423 DOI: 10.1016/s0168-8278(02)00161-7] [Cited by in Crossref: 38] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Castellani C, Cuppens H, Macek M, Cassiman JJ, Kerem E, Durie P, Tullis E, Assael BM, Bombieri C, Brown A, Casals T, Claustres M, Cutting GR, Dequeker E, Dodge J, Doull I, Farrell P, Ferec C, Girodon E, Johannesson M, Kerem B, Knowles M, Munck A, Pignatti PF, Radojkovic D, Rizzotti P, Schwarz M, Stuhrmann M, Tzetis M, Zielenski J, Elborn JS. Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice. J Cyst Fibros. 2008;7:179-196. [PMID: 18456578 DOI: 10.1016/j.jcf.2008.03.009] [Cited by in Crossref: 370] [Cited by in F6Publishing: 315] [Article Influence: 26.4] [Reference Citation Analysis]
2 Pollheimer MJ, Halilbasic E, Fickert P, Trauner M. Pathogenesis of primary sclerosing cholangitis. Best Pract Res Clin Gastroenterol 2011;25:727-39. [PMID: 22117638 DOI: 10.1016/j.bpg.2011.10.009] [Cited by in Crossref: 72] [Cited by in F6Publishing: 65] [Article Influence: 7.2] [Reference Citation Analysis]
3 Trauner M, Fickert P, Halilbasic E, Moustafa T. Lessons from the toxic bile concept for the pathogenesis and treatment of cholestatic liver diseases. Wien Med Wochenschr. 2008;158:542-548. [PMID: 18998069 DOI: 10.1007/s10354-008-0592-1] [Cited by in Crossref: 73] [Cited by in F6Publishing: 68] [Article Influence: 5.6] [Reference Citation Analysis]
4 Chapman R, Cullen S. Etiopathogenesis of primary sclerosing cholangitis. World J Gastroenterol 2008; 14(21): 3350-3359 [PMID: 18528932 DOI: 10.3748/wjg.14.3350] [Cited by in CrossRef: 63] [Cited by in F6Publishing: 51] [Article Influence: 4.5] [Reference Citation Analysis]
5 Sheth S, Shea JC, Bishop MD, Chopra S, Regan MM, Malmberg E, Walker C, Ricci R, Tsui LC, Durie PR, Zielenski J, Freedman SD. Increased prevalence of CFTR mutations and variants and decreased chloride secretion in primary sclerosing cholangitis. Hum Genet 2003;113:286-92. [PMID: 12783301 DOI: 10.1007/s00439-003-0963-z] [Cited by in Crossref: 71] [Cited by in F6Publishing: 63] [Article Influence: 3.7] [Reference Citation Analysis]
6 Bowlus CL. Cutting edge issues in primary sclerosing cholangitis. Clin Rev Allergy Immunol 2011;41:139-50. [PMID: 21170605 DOI: 10.1007/s12016-010-8221-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
7 Hagymási K, Tulassay Z. Genetic background of the multifactorial liver and bile duct diseases. Orvosi Hetilap 2007;148:147-53. [DOI: 10.1556/oh.2007.27987] [Reference Citation Analysis]
8 Karlsen TH, Schrumpf E, Boberg KM. Genetic epidemiology of primary sclerosing cholangitis. World J Gastroenterol 2007; 13(41): 5421-5431 [PMID: 17907284 DOI: 10.3748/wjg.v13.i41.5421] [Cited by in CrossRef: 52] [Cited by in F6Publishing: 39] [Article Influence: 3.5] [Reference Citation Analysis]
9 Rosmorduc O, Poupon R. [Hepatobiliary transporters: from genomics to diseases]. Gastroenterol Clin Biol 2004;28:D112-20. [PMID: 15213671 DOI: 10.1016/s0399-8320(04)94995-0] [Reference Citation Analysis]